McKesson ($MCK) Insider Trading & Smart Money Activity

McKesson Corporation · Medical Distribution · Latest filing Oct 16, 2026

McKesson Corporation ($MCK) has 1 insider trade, 4 congress trades, 13 13F position changes and 3 analyst ratings on file. In the last 12 months on the open market, no insider bought and 1 insider sold ($6.56M), net -$6.56M.

Insider buyers (12 mo)
0
Insider sellers (12 mo)
1
Net insider $ (12 mo)
-$6.56M
Congress trades (12 mo)
3
13F moves on file
13
Analyst ratings on file
3

MCK insider buying and selling by quarter

QuarterInsider buysInsider salesCongress buys / sales13F added / cut
Q1 2026 0 0 1 / 0 0 / 0
Q2 2026 0 1 · $6.56M 0 / 1 5 / 6
Q3 2026 0 0 1 / 0 0 / 0
Q4 2026 0 0 0 / 0 1 / 1

Insider buys and sales count open-market trades only (Form 4 codes P and S). Grants, option exercises and tax withholding are left out.

All MCK insider, congress, 13F and analyst activity

DateSourceWhoActionSharesValue / amount ΔOwn1W1M6MFilingStory
Analyst UBS Reiterates to Buy PT $1,200 Read
13F GHP Investment Advisors Added +1.74K sh $19.12M —
13F Patriot Financial Group Insurance Agency Reduced -1.99K sh $279.40K —
Analyst Leerink Partners Reiterates to Outperform PT $1,070 +7.3% —
Congress Rick Larsen Purchase $1,001 - $15,000 -2.7%+6.2% —
Insider Brian TylerChief Executive Officer Sell (Open-market sale) 10b5-1 8.46K sh $6.56M -1.7%+7.9% Read
Congress Jonathan L. Jackson Sale $1,001 - $15,000 -4.5%+2.1% —
Analyst Barclays Reiterates to buy PT $925 -1.3%+2.0% —
13F Lone Pine Capital New +392.22K sh $296.36M +0.7%+2.6% Read
13F Farallon Capital Management Reduced -64.60K sh $177.04M +0.7%+2.6% —
13F Brandes Investment Partners Reduced -15.88K sh $130.33M +0.7%+2.6% Read
13F Boston Partners Reduced -74.70K sh $872.75M +7.0%+9.1% —
13F Boston Partners Reduced -74.70K sh $909.24M +7.0%+9.1% —
13F Sands Capital Management Added +27.02K sh $152.09M +3.3%+4.3% —
13F Wcm Investment Management Reduced -11.95K sh $704.31M -1.0%+1.7% —
13F Wcm Investment Management Reduced -11.95K sh $730.83M -1.0%+1.7% —
13F Candriam S.C.A. Added +33.49K sh $181.09M -7.4%-9.8% —
13F Swedbank Added +119.33K sh $759.84M -9.6%-9.7% —
13F Swedbank Added +119.33K sh $791.61M -9.6%-9.7% —
Congress Alan Armstrong Purchase $1,001 - $15,000 -0.4%-3.7%+1.0% —
Congress Ritchie Torres Purchase $1,001 - $15,000 —

1W / 1M / 6M = how MCK moved from the trade or filing date.

Insider trading in MCK: who is buying and selling

InsiderRoleTradesOpen-market netShares heldLast trade
Brian Tyler Chief Executive Officer 1 -$6.56M Jun 17, 2026

Members of Congress trading MCK

Institutions moving MCK (13F)

Analyst ratings on MCK

DateFirmActionRatingPrice target1W1M6MStory
UBS Reiterates Buy $1,080 → $1,200 Read
Leerink Partners Reiterates Outperform $1,030 → $1,070 +7.3% —
Barclays Reiterates buy $925 -1.3%+2.0% —

Frequently asked questions

Are MCK insiders buying or selling?

Over the last 12 months 0 insiders made 0 open-market purchases worth $0 and 1 insider made 1 open-market sale worth $6.56M, a net -$6.56M.

What is the latest insider trade in MCK?

Brian Tyler, Chief Executive Officer filed a sell (open-market sale) of 8.46K sh worth $6.56M on Jun 17, 2026.

Which members of Congress traded MCK?

4 disclosed trades by Rick Larsen, Jonathan L. Jackson, Alan Armstrong and Ritchie Torres. The latest was on Jul 8, 2026.

Which institutions changed their MCK positions?

Recent 13F filers moving the stock include Boston Partners, Wcm Investment Management, Swedbank, GHP Investment Advisors and Patriot Financial Group Insurance Agency.

Other medical distribution stocks

Data comes from public SEC Form 4 and 13F filings and STOCK Act disclosures. Dates are the trade or filing date reported. This page is for research only and is not investment advice.

Get trade alerts by text